Pillstats
Rx only · Capsule · Oral

Fluvastatin

Fluvastatin Sodium

3 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US9 NDCs
3 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)41127
US makers3 labelers
Packages13
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 8 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.862$1.72$2.59$3.45Dec 2025Apr 2026Jul 2026
$2.903
Latest avg · Jul 22, 2026
-3%
Since Dec 17, 2025
3
Active US suppliers
69%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

931852783702025 Q12025 Q22025 Q32025 Q42026 Q1
249
Rx · 2026 Q1
13K
Units dispensed
-21%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it3 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Bryant Ranch Prepackrepackager5SUPPLYING
Teva Pharmaceuticals USA, Inc.unknown4SUPPLYING
Mylan Pharmaceuticals Inc.unknown4SUPPLYING

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • May 29, 2014
    RECALLRecall (Class II): Fluvastatin Capsules USP, 20 mg, Rx Only, 30-count bottle, manufactured for Teva Pharmaceuticals, Sellersville, PA, by …

    Failed Tablet/Capsule Specifications: Teva Pharmaceuticals USA, Inc. is voluntarily recalling one lot of Fluvastatin Capsules USP, 20 mg due to a customer complaint trend regarding capsule breakage. — Recalling firm: Teva Pharmaceuticals USA — Nationwide and Guam, Puerto Rico, American Samoa, Virgin Islands